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Abstract
To avoid excessive activation, immune signals are tightly controlled by diverse inhibitory proteins. TRIM30, a tripartite motif
(TRIM)-containing protein is one of such inhibitors known to function in macrophages. To define the roles of TRIM30, we
generated Trim30 knockout (Trim302/2) mice. Trim30 deletion caused no major developmental defects in any organs, nor
showed any discernable defect in the activation of macrophages. But, Trim302/2 mice showed increased CD4/CD8 ratio
when aged and Trim302/2 CD4+ T cells exhibited an abnormal response upon TCR activation, in particular in the absence of
a costimulatory signal. Adoptive transfer of wild-type and Trim302/2 CD4+ T cells together into lymphopenic hosts
confirmed higher proliferation of the Trim302/2 CD4+ T cells in vivo. Despite the enhanced proliferation, Trim302/2 T cells
showed decreased levels of NF-kB activation and IL-2 production compared to wild-type cells. These results indicate a
distinct requirement for TRIM30 in modulation of NF-kB activation and cell proliferation induced by TCR stimulation.
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Introduction
Lymphocyte proliferation is important for proper response to
infection, but uncontrolled proliferation predisposes individuals to
lymphoproliferative disorders (LDs) or autoimmune disease [1,2].
Therefore, peripheral T cells exhibit inhibitory mechanisms to
control the two major signals of T cell activation: the MHC-TCR
interaction and the CD28 costimulation. Several E3 ligases
including Protein pellino homolog 1 (PELI1), Gene Related to
Anergy In Lymphocytes (GRAIL), Casitas B-lineage lymphoma b
(Cbl-b) appear to play important roles in the downregulation of
TCR signals [3]. PELI1 negatively regulates c-Rel by mediating
ubiquitination of Lys48 during T-cell activation [4]. Casitas B-
lineage lymphoma b (Cbl-b) negatively regulates GDP/GTP
exchange factor Vav1 phosphorylation [5], while GRAIL
promotes CD3 receptor ubiquitination, leading to degradation
[6]. Knockout of these E3 ligases in mice results in a high
susceptibility to autoimmune diseases [4,7,8] in these animals,
indicating that E3 ligase-mediated degradation of TCR signaling
molecules is a major inhibitor of T cell activation.
The tripartite motif-containing TRIM [also called ring-B box-
coiled coil motif (RBCC)] proteins belong to the RING-type E3
ligase family [9], and many of these ligases have been implicated in
regulation of the immune response [10,11]. Human TRIM5a acts
as a retroviral restriction factor that recognizes retroviral capsids
[12] and promotes innate immune signaling [13,14]. Mouse
TRIM30, a human TRIM5a homolog, was shown to downreg-
ulate TLR-mediated NF-kB signaling by targeting TAK1-binding
protein 2 (TAB2) and TAK1-binding protein 3 (TAB3) for
degradation using siRNA-mediated knockdown experiments [15].
Downregulation of NACHT, LRR, and PYD domains-containing
protein 3 (NLRP3) during inflammasome activation by reactive
oxygen species also requires TRIM30 [16].
In addition to these regulatory function of TRIM30 in
macrophages and dendritic cells, high levels of TRIM30
expression are observed in diverse lymphocyte populations [15]
and are inversely related to IL-2R expression in T cells [17];
however, whether TRIM30 controls the NF-kB pathway in
lymphocytes is not known. To determine the physiological
function of TRIM30 and its role in lymphocytes, we generated
Trim30 knockout mice. Interestingly, we found no major defects in
the activation of macrophages, but Trim302/2 CD4+ T cells
exhibited enhanced proliferation and cell cycle progression upon
TCR stimulation both in vitro and in vivo compared to wild-type
cells; however, CD4+ T cell activation mediated by CD3
stimulation was compromised, particularly with regard to the
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Figure 1. Generation of Trim30 knockout mice. (A) A diagram representing the targeting construct, the Trim30 gene locus (Wild-type locus), and
the locus after targeting (Targeted locus). The targeting construct contains a stop codon and a neomycin selectable marker in exon 2 of Trim30. (B)
Genomic DNA fragments from Trim30+/2 and Trim302/2 progeny after Southern blotting with NcoI digestion. Wild-type alleles (10 kb) and the
targeted alleles (8 kb) are indicated. (C) Genomic DNA isolated from Trim30+/+, Trim302/2, and Trim30+/2 was subjected to PCR. (D) Tissue Trim30
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activation of NF-kB signaling. These findings revealed distinct
roles for TRIM30 during the activation of naı¨ve T cells upon TCR
stimulation.
Results
Abnormal Age-associated CD4/CD8 Ratio in Trim302/2
Mice
To understand the physiological function of TRIM30, we
generated Trim30 knockout mice. The second exon, which
contains the start codon, was replaced with a neomycin selection
cassette following a stop codon (Figure 1A), and the targeted
construct was germ-line transformed to generate chimeric
Trim30+/2 mice, which were confirmed both by Southern
blotting- and PCR-based genotyping (Figure 1B–C). The inter-
cross of the Trim30+/2 heterozygotes produced offspring at the
expected Mendelian ratio, indicating that the mutants experienced
no obvious developmental defects associated with Trim30 deletion.
RT-PCR analysis revealed high Trim30 transcript levels in
lymphoid organs (spleen, thymus, and lymph node) and bone
marrow in contrast to the low levels of Trim30 transcripts in non-
hematopoietic tissues (Figure 1D). The high levels of basal and
induced expression of Trim30 in lymphocytes and macrophages
were absent in the Trim30 knockout mouse. Immunoblot analysis
of various tissues also confirmed the loss of TRIM30 protein
expression in the lymph nodes, spleen, and thymus of Trim302/2
mice (Figure 1E).
To validate its suggested role in NF-kB activation in macro-
phages, Trim30+/+ and Trim302/2 bone marrow derived
macrophages (BMDMs) were challenged with LPS or poly I:C
then compared for their cytokine responses. The challenge with
TLR ligands induced TRIM30 strongly only in wild-type cells, but
there was no discernable difference in the expression of the major
cytokines (IL-6, TNFa, IL-12 p40, IFNa, IFNb) (Figure 1F). Besides,
Trim302/2 mice showed no defect in resistance to LPS-induced
septic shock, as well as in the response to Listeria monocytogenes
infection (Figure 1G). Therefore, TRIM30 appears dispensable for
most TLR activations in macrophages.
In contrast to the inducible expression of Trim30 in macro-
phages, the high basal levels observed in lymphoid organs suggest
that TRIM30 protein may be involved in the regulation of
lymphocytes. To this end, we first assessed TRIM30 expression in
T cells. Immunoblot analysis revealed that TRIM30 is highly
expressed in both CD4+ T cells and CD8+ T cells purified from
wild-type spleens (Figure 2A). TRIM30 is abundant in the naı¨ve T
cells, and high levels of TRIM30 were maintained after T cell
activation with anti-CD3/CD28 antibodies or PMA/ionomycin
costimulation (Figure 2B). Comparison of T lymphocyte popula-
tions in thymus from Trim30+/+ and Trim302/2 mice revealed no
differences in the proportions of double-negative (DN), double-
positive (DP), CD4 single-positive (SP), or CD8SP thymocytes
(Figure 2C). In addition, the four DN populations, which were
sorted based on the expression of CD25 and CD44, were
comparable in Trim30+/+ and Trim302/2 mice (Figure 2D).
Therefore, the development of T cells appeared normal in the
Trim30 mutant mice. However, comparison of aged mice revealed
significant difference in the ratios of peripheral CD4/CD8 T cells
(Figure 2E). As mice age, the relative ratio between CD4+ and
CD8+ T cells gradually decreases [18,19]; however, in aged
Trim302/2 mice, the CD4/CD8 ratio remained high in the spleen
and lymph nodes. Absolute number of CD4+ T cells was slightly
increased in Trim302/2. Difference in CD4/CD8 ratio was due to
more abundant CD4+ T cells in Trim302/2 mice. These finding
suggest that long-term peripheral maintenance of T cells is
dysregulated in Trim302/2 mice.
Hyper-proliferation of Trim302/2 CD4+ T cells
We further investigated the role of TRIM30 in the response of
CD8+ and CD4+ T cells in vitro. We labeled purified Trim30+/+
and Trim302/2 splenic T cells with the division-tracking dye
CFSE, and then stimulated the cells for 72 h with anti-CD3
antibody in the presence or absence of costimulation with anti-
CD28 antibody. Upon stimulation with anti-CD3 agonist
antibody, 74% of the Trim302/2 CD4+ T cells proliferated, while
only 40% of the CD4+ T cells proliferated in wild type mice
(Figure 3A). The proliferation disparity between Trim30+/+ and
Trim302/2 CD4+ T cells decreased upon stronger stimulation in
the presence of costimulatory signal. When cells were stimulated
with PMA and ionomycin, which bypass TCR signaling,
proliferation of Trim302/2 cells was comparable to that of
Trim30+/+cells. These hyper-proliferation defects appeared specific
to CD4+ T cells because CD8+ T cells from Trim302/2 mice
proliferated normally in response to these stimuli (Figure 3B).
Therefore, TRIM30 seemingly represses premature CD4+ T cell
proliferation, particularly in the absence of a costimulatory signal
for TCR activation.
Subsequently, we determined whether hyper-proliferation of
Trim302/2 CD4+ T cells is also observed during antigen-specific T
cell stimulation. To this end, we isolated splenocytes from
Trim302/2 mice crossed with OT-II transgenic mice. Consistent
with the above results, Trim302/2 OT-II CD4+ T cells exhibited
10–20% enhanced proliferation compared with Trim30+/+ OT-II
CD4+ T cells, particularly when stimulated with a low dose of
OVA323–339 peptide (Figure 3C). We cannot rule out the
possibility of that loss of Trim30 might also compromise antigen
presenting cells function. Nevertheless, we detected a normal
cytokine expression in Trim302/2 macrophage, a type of antigen
presenting cells (Figure 1F), and the hyper-proliferation was more
clear when only CD4+ T cells were used (Figure 3A). Overall,
these data indicate that TRIM30 negatively regulates CD4+ T cell
proliferation following TCR activation in the absence of
costimulatory signaling or low levels of TCR-specific antigens.
Increased Cell Cycle Progression in Trim30 Knockout T
cells
To assess the role of TRIM30 in CD4+ T cell proliferation, we
analyzed the cell cycle progression of Trim302/2 CD4+ T cells.
mRNA expression from Trim30+/+ and Trim302/2mice. RT-PCR analysis revealed high Trim30 transcript levels in lymphoid organs (spleen, thymus, and
lymph node) and bone marrow in contrast to the low levels of Trim30 transcripts in non-hematopoietic tissues (E) TRIM30 protein expression level in
tissues from Trim30+/+ and Trim302/2 mice as determined with immunoblotting using anti-Trim30 antibody. *, non-specific signal. (F) BMDMs were
stimulated with LPS (200 ng/ml) or poly(I:C) (5 mg/ml), and Trim30 transcripts were quantified by quantitative RT-PCR. For detection of cytokine
expression, Trim30+/+ and Trim302/2 BMDMs were pretreated for 18 hr with LPS (LSP pre) and then restimulated with LPS (LPS re) indicated time or
stimulated with poly(I:C) and transcripts for indicated cytokines were quantified by quantitative RT-PCR. Expression was normalized to GAPDH. (G)
Survival of mice (n = 14 per group) given i.p injection of LPS (20 mg/kg) (upper panel). Survival of mice (n = 18 per group) given i.p infection of Listeria
monocytogenes (26106 CFU per mouse) (lower panel). Data are representative results from three independent experiments. Error bars in D, E, F
indicate s.d.
doi:10.1371/journal.pone.0095805.g001
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Figure 2. T cell lymphoid organ developmental progression is normal in Trim30 knockout mice. Immunoblot analysis of Trim30
expression in splenocytes and purified CD4+ and CD8+ T cells that were (A) unstimulated or, b-actin was used as a loading control (B) stimulated with
anti-CD3 (2 mg/ml) and anti-CD28 (2 mg/ml) antibodies (CD3/CD28) or with 10 ng/ml of PMA and 500 ng/ml of ionomycin (P/I) for 3 days. GAPDH was
used as a loading control. (C) Representative flow cytometric plots for CD4 and CD8 expression in the thymocyte population from Trim30+/+ and
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Upon CD3 stimulation for 72 h, both Trim30+/+and Trim302/2
CD4+ T cells exhibited a sharp increase in BrdU and 7AAD
incorporation, representing active DNA synthesis in S phase.
However, more Trim302/2 (72.8%) than wild-type (49.3%) CD4+
T cells were found in S phase with a concomitant decrease in the
corresponding cells in G0 phase (Figure 4A). To determine
whether Trim30 deletion has any effect on cell viability after TCR
signaling, early and late apoptosis was analyzed by annexin V and
PI staining (Figure 4B). CD3 stimulation sharply increased cell
viability in both Trim30+/+and Trim302/2 CD4+ T cells and
resulted in no difference in the percentage of annexin V+PI2 cells
(early apoptotic cells) or annexin V+PI+ cells (late apoptotic cells).
Therefore, Trim30 deficiency caused cell cycle hyper-progression
into S phase but did not affect CD4+ T cell death.
We next investigated the expression of cell cycle regulators.
Immunoblot analysis showed that in Trim30+/+ CD4+ T cells,
retinoblastoma (Rb) protein phosphorylation and p27kip expres-
sion were down- and up-regulated, respectively, 48 h after anti-
CD3 stimulation (Figure 4C); however, Trim302/2 CD4+ T cells
exhibited an earlier response in these expression patterns only
24 h after anti-CD3 stimulation. These results suggest that cell
cycle progression in CD4+ T cells is indeed stimulated by the loss
of TRIM30.
Higher Proliferation of Trim30 Knockout T cells in Rag1-
deficient Mice
To confirm the physiological relevance of the enhanced
proliferative phenotype of Trim302/2 T cells in vitro, we
determined whether Trim30 deletion influenced the homeostatic
proliferation of T cells in lymphocyte-deficient mice. We purified
CD4+ T cells from both Trim302/2 and wild-type mice, which
expressed congenic markers CD45.2 and CD45.1, respectively,
and labeled these cells with CFSE. In vitro-labeled wild type and
Trim302/2 CD4+ T cells were mixed at a 1:1 ratio and transferred
to Rag12/2 recipient mice, which lack B and T cells (Figure 5A).
The relative amounts of wild-type control and Trim302/2 splenic
CD4+ T cells that were distinctly marked with the CD45.1+ and
CD45.12, respectively, were determined 4 days after the adoptive
transfer. After selection of the adoptively transferred T cells using
CD3 and CD4 markers, cell proliferation was analyzed by CFSE
dilution (Fig. 5A). The competitive repopulation of adoptively
transferred wild-type and Trim302/2 T cells revealed that the
proliferating populations contained a significantly greater propor-
tion of Trim302/2 T cells compared to Trim30+/+ cells. Thus,
twice the number of Trim302/2 T cells was detected in the
recipient Rag12/2 mice after 4 days compared to wild-type T cells
(Fig. 5B–C). These findings confirmed the negative function of
TRIM30 in lymphopenia-induced T cell proliferation.
Reduced Effector Function of Trim302/2 CD4+ T cells
The above results indicate that TRIM30 raises the activation
threshold required for T cell proliferation. Therefore, in the
absence of Trim30, T cells began to proliferate in response to even
weak activation signals from the TCR. Because TCR engagement
promotes effector function as well as proliferation, we also
analyzed the defects caused by Trim30 deletion on T cell effector
functions under the same conditions. Contrary to our expecta-
tions, Trim302/2 CD4+ T cells produced consistently lower levels
of IL-2 compared to Trim30+/+ CD4+ T cells upon stimulation
with anti-CD3 antibody (Figure 6A). In addition, expression of
CD25 and CD69, which mark early T cell activation, was also
reduced in Trim302/2 CD4+ T cells compared to wild-type CD4+
T cells (Figure 6B); however, these defects were greatly diminished
when cells were strongly stimulated with anti-CD3 and anti-CD28
agonists. Therefore, Trim30 deletion enhanced T cell proliferation
but resulted in a higher threshold for activation of effector function
via TCR activation.
We then investigated the mechanisms underlying this enhanced
CD4+ T cell proliferation and decreased effector function in
Trim302/2 mice. We stimulated CD4+ T cells for 90 min with
anti-CD3 antibodies and then examined cell lysates for phosphor-
ylation of classical TCR signaling molecules. Activation of classical
TCR signaling pathways, including the ERK, JNK, and p38
kinases, appeared similar in Trim302/2 and Trim30+/+ CD4+ T
cells, although phosphorylation of IkB was lower in Trim302/2
CD4+ T cells (Figure 6C). These observations suggest that
TRIM30 is required for NF-kB activation following TCR
activation with anti-CD3 agonist and that this effect occurs
without enhancing proliferation during TCR activation in the
absence of costimulatory signals.
Discussion
TRIM30 is the mouse homolog of human TRIM5a protein,
which exerts an anti-retroviral function in various cell types;
however, to date, the role of TRIM30 in mice has been linked only
with innate immune responses in macrophages and dendritic cells
[15,16,20]. In this report, we established TRIM30 as a key
regulator of TCR-induced signaling in CD4+ T cells. A lack of
TRIM30 caused increased proliferation and cell cycle progression
upon TCR cross-linking with anti-CD3 agonist. Furthermore,
TRIM30 deficiency led to a high CD4/CD8 ratio in aged mice
and increased expansion of adoptively transferred CD4+ T cells in
lymphopenic hosts. Another interesting feature of Trim302/2
CD4+ T cells is the relatively lower effector function upon CD3
ligation, despite a highly proliferative phenotype. Thus, suppres-
sion of T cell proliferation concomitant with promotion of the
effector function via TRIM30 may be required to prevent
abnormal proliferation of T cells in the absence of optimal T
cell activation signals, allowing adequate time for cells to properly
differentiate into the correct T cell types before full activation.
Trim302/2 CD4+ T cells show the enhanced proliferation
despite the reduced IL-2 production. We suggest that TRIM30
mediates T cell expansion through IL-2-independent proliferation.
In vitro and in vivo studies present the evidence for IL-2-
independent cell cycle regulatory mechanisms [21,22]. These
studies established that IL-2-independent mechanisms are in-
volved in TCR/CD28 mediated cell cycle controlling [23,24].
Reduced p27kip expression and enhanced phosphorylation of Rb
in Trim302/2 CD4+ T cells suggest this possibility.
Trim302/2mice. The average percentages and absolute cell number of CD42CD82 double negative (DN), CD4+CD8+ double positive (DP), and CD4+
or CD8+ single positive (CD4SP, CD8SP) thymocytes from four independent experiments are shown on the right. (D) Representative flow cytometric
plots for CD44 and CD25 expression in the identified DN1 (CD44+CD252), DN2 (CD44+CD25+), DN3 (CD442CD25+), and DN4 (CD442CD252) T cell
populations. DN1-DN4 thymic populations and absolute cell number from four experiments are shown on the right. (E) Ratios of CD4/CD8 on lymph
node cells and splenocytes isolated from 10-week- (young) and 12-month-old (aged) Trim30+/+ and Trim30 knockout mice. For this analysis, at least
four young mice or 12 aged mice were analyzed. Absolute cell number of independent experiment are shown on the right. The P-value was
calculated using a t–test. *, P,0.05; ***, P,0.0005. Error bars in C, D, and E represent the s.d.
doi:10.1371/journal.pone.0095805.g002
Modulation of CD4+ T Cell Function by Trim30
PLOS ONE | www.plosone.org 5 April 2014 | Volume 9 | Issue 4 | e95805
Figure 3. Enhanced proliferation of Trim302/2 CD4 T cells. (A) Purified CD4+ T cells from Trim30+/+ and Trim302/2 spleens were labeled with
CFSE and cultured with the indicated supplements (No, medium; CD3, 2 mg/ml of plate-coated anti-CD3 antibody; CD3/CD28, 2 mg/ml of plate-
coated anti-CD3 antibody and soluble anti-CD28 antibody; PMA+Ionomycin, 10 ng/ml of PMA and 500 ng/ml of ionomycin) for 3 days. The CFSE
intensity of the CD4+ T cells was measured with flow cytometry, and representative plots for Trim30+/+ and Trim302/2 T cells are shown with the
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Recent studies showed that proliferation and effector function
are regulated by different mechanisms [25,26]. For example, the
metabolic switch from oxidative phosphorylation to aerobic
glycolysis is specifically required for effector function in T cells
but not for proliferation [25]. On the other hand, a high
multiplicity of TCR ITAM is required for T cell proliferation,
whereas a low multiplicity of CD3 ITAM was sufficient to lead to
cytokine secretion [26]. Therefore, activation of effector functions
and proliferation upon TCR stimulation can be regulated
independently.
Although both CD4+ and CD8+ T cells express TRIM30, our
results show that the hyper-proliferation caused by Trim30 deletion
is only appear in CD4+ T cells, but not in CD8+ T cells. Because
purified CD4+ T cells by using CD4 T Cell Isolation Kit contain
Treg cells, the possibility of non-autonomous roles of Trim30 in
Treg cells still exist. The percentage of Treg cells (CD25+Foxp3+)
in splenic CD4+ T cells was 9 to 10%, but there was no difference
in their abundance between Trim30+/+ and Trim302/2 mouse
(data not shown). It is necessary to follow-up studies addressing the
roles of Trim30 in Treg and CD8+ T cells, albeit not to
proliferation mechanism.
Notably, the effects of TRIM30 deficiency were apparent only
when cells were stimulated with weak T cell activation signals. T
cells should be resistant to activation following weak stimulatory
signals in order to avoid hyperactivation of immune responses. We
propose that TRIM30 regulates the threshold to effector function
and proliferation in the presence of incomplete T cell stimulation;
although, strong stimuli may override the regulatory activity of
TRIM30 and induce TCR-mediated T cell activation.
In contrast to previous reports on Trim30 knockdown or
overexpression in monocytes [15,16], we observed reduced NF-kB
activation in Trim302/2 CD4+ T cells. This discrepancy may
result from differences in the experimental conditions used in these
studies (cell line-based Trim30 knockdown vs. Trim30 knockout
mouse) or from difference in the tissue types (macrophage vs. T
cells). Intriguingly, similar differences were also observed in the
analysis of TAB2 and TAB3 mutant mice. TAB2 and TAB3,
which are involved in NF-kB activation in monocytes (21), were
reported as putative TRIM30 targets in knockdown experiment
(13); however, TAB2 knockout mice have normal IL-1b produc-
tion in response to IL-1R signaling [27]. A recent study of TAB2
and TAB3 knockout mice revealed that TAB2 and TAB3 are
dispensable for activation of NF-kB and MAPKs in macrophages
and MEFs [28]. Instead, TAB2 and TAB3 were shown to have
critical role to control B cell activation by specifically regulating
MAPKs [28]. Although the exact role of TRIM30 remains to be
elucidated, our data showed that TRIM30 is required for optimal
effector function of CD4+ T cells via NF-kB activation and
concomitantly negatively regulates the proliferation of these T
cells.
Materials and Methods
Ethics Statement
All animal experiments were performed in accordance with the
Korean Food and Drug Administration (KFDA) guidelines.
Protocols were reviewed and approved by the Institutional Animal
Care and Use Committee (IACUC) of the Yonsei Laboratory
Animal Research Center (YLARC) at Yonsei University (Permit
Number: 2008-0012).
Animal and Infection
All mice were maintained in the specific pathogen-free facility of
the YLARC at Yonsei University following the IACUC guidelines.
In experiments for survival study, male six- to ten-week-old
littermate (22.961.6 g) Trim30+/+ and Trim302/2 mice
(n= 14,18 per group) were used. Mice were challenged with
LPS (20 mg/kg) or Listeria Monocytogenes (26106 CFU per
mouse) by intraperitoneal (i.p) route. The experiment was repeated
3,4 times, and data were pooled. The Kaplan-Meier method was
used to plot survival curve. Survival and health status of infected
mice were monitored daily. Mice reaching the humane endpoint
(compound-related severe illness, as indicated by inability to eat
and drink or a lack of response when gently prodded with a
forceps) were euthanized by cervical dislocation under anesthesia
with isoflurane. All mice were sacrificed by same method.
Gene Targeting
Trim30 knockout mice were generated using homologous
recombination. A short (1.7 kb) and long (6.3 kb) arm were
obtained from a C57BL/6J BAC clone (Children’s Hospital
Oakland BACPAC Resources) using PCR. The following primers
were used: short arm forward primer (59-CCCATCGATAGACT-
TACACCAAGAT-39), reverse primer (59-GCGGAATTCT-
CAGCACTCACAGG-39), long arm, forward primer (59-
CCCGAATTCACAGGGTACTTACC-39), and reverse primer
(59- AAAGCGGCCGCCAGCATTTCTAA-39). Products were
ligated into the gene-targeting cassette vector pGK-TK-Neo and
electroporated into 129/Sv E14 embryonic stem (ES) cells. Cells
positive for homologous recombination were selected with G418
and ganciclovir and screened using Southern blotting. Positive ES
cells were then injected into C57BL/6 blastocysts in the transgenic
facility at the Ewha Laboratory Animal Genomic Center (Korea).
Chimeras containing the target allele were backcrossed to C57BL/
6 animals, and experiments were performed with mice that were
backcrossed for more than 10 generations. For genotyping,
genomic DNA was extracted from mouse tail biopsies, and PCR
amplification was performed using the following primers:
TRIM30 WT forward (59-CAGGTGGAAAACCTC-
CACTTTTGC-39), TRIM30 reverse (59-CCCCATTGTT-
GAAAGTCACTAGATAGC-39), and NEO KO forward (59-
GCCTTCTAGTTGCCAGCCATCTGTT-39).
Media, Reagents, and Antibodies
Lymphocytes were cultured in RPMI 1640 supplemented with
10% heat-inactivated FBS, 100 U/ml penicillin and streptomycin,
2 mM L-glutamine (Gibco), and 50 mM 2-mercaptoethanol
(Sigmal-Aldrich, St. Louis, MO). The following reagents and
antibodies were purchased from BD Pharmingen (San Jose, CA):
7AAD; annexin V; PI and anti-mouse CD4 (L3T4), CD8 (53-6.7),
CD25 (7D4), CD69 (H1.2F3), CD44 (IM7), CD3e (145-2C11)
antibodies. In addition, the following reagents and antibodies were
used: CFSE (Invitrogen, Carlsbad, CA), PMA (Sigma-Aldrich),
and ionomycin (Sigma-Aldrich), as well as anti-TRIM30
percentages of the dividing cells given as those with diluted levels of CFSE staining. (B) Purified CD8+ T cells from Trim30+/+ or Trim302/2 mouse
spleens were analyzed as described above for (A). (C) Splenocytes from Trim30+/+and Trim302/2OT-II mice were activated with the indicated
concentration of Ova 323–339 peptide for 3 days. Proliferation of T cells was measure by CFSE intensity after gating for CD4+ cells. The results of four
independent measurements are shown on the right. The P-value was calculated using the t–test. *; P,0.05; **, P,0.005, ns; not significant. Error bars
represent s.d.
doi:10.1371/journal.pone.0095805.g003
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Figure 4. Modulation of the cell cycle in Trim302/2 CD4+ T cells. (A) The cell cycle profile of Trim30+/+and Trim302/2 CD4+ T cells with (CD3) or
without (No) anti-CD3 stimulation for 3 days. Each phase of the cell cycle was determined according to the levels of BrdU and 7AAD incorporated into
the cells. The percentage of cells in each phase of the cell cycle is shown. The average of six independent experiments is shown error bars on the
Modulation of CD4+ T Cell Function by Trim30
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(ab76953; Abcam, Cambridge, UK), anti-b-actin (4967; Cell
Signaling, Danvers, MA), anti-GAPDH (sc25778; Santa Cruz,
CA), and anti-IkB (sc371; Santa Cruz) antibodies. OVA peptide
(323–339) was synthesized by AnyGen (Korea).
Primary T Cell Culture, Proliferation Assay, and in vitro
Differentiation
T cells were isolated from spleens using a CD4 T Cell Isolation
Kit and a CD8 T Cell Isolation Kit (Miltenyi Biotech, Auburn,
CA). T cells were labeled for 7 min with 1.25 mM CFSE, followed
by termination with 1/10 volume of FBS. Cells were washed 3
times. Labeled cells were cultured in pre-coated plates with anti-
CD3 (145-2C11) and soluble anti-CD28 antibodies (37.51) (BD).
The BrdU Flow kit (BD) was used to identify cell cycle populations
in vitro. BrdU was added to cell cultures with anti-CD3 and
soluble anti-CD28 antibodies during the final 7 h of culture. For
ova peptide stimulation, splenocytes from OT-II mice were
cultured with OVA peptide (323–339).
Flow Cytometry Analysis
We isolated mononuclear cells from thymus, spleen, and lymph
nodes of Trim30+/+ and Trim302/2 mice. These cells were stained
with antibodies to surface antigens for 30 min at 4uC. After several
washes, cytofix/cytoperm was added and incubated for 30 min at
4uC. CD4+ T cell apoptosis was assessed using annexin V-FITC
and propidium iodide (PI) staining. Samples were loaded on a
FACS Calibur, and data analyses were performed with Flow Jo
software.
Quantitative Real-time PCR
Total RNA was isolated using the Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. Then, cDNA was
right. The P-values were calculated with a t –test. *, P,0.05. (B) Apoptotic ratio of Trim30+/+ and Trim302/2 CD4+ T cells with (CD3) or without (No)
anti-CD3 stimulation. The percentages of cells in early (annexin positive and PI negative) and late (double positive) apoptosis are given along with
those of the viable cells (double negative). The average of five independent experiments is presented with error bars on the right. (C) Immunoblot
analysis of cell cycle proteins in whole cell lysates of purified Trim30+/+and Trim302/2 CD4+ T cells following stimulation with the anti-CD3 antibody
(2 mg/ml) using the indicated antibodies for the indicated time period. Error bars in A and B denote s.d.
doi:10.1371/journal.pone.0095805.g004
Figure 5. Trim30 is important for in vivo CD4+ T cell homeostasis. (A) CD4+ T cells isolated from CD45.2+ Trim302/2 and CD45.1+ wild-type
congenic mice were labeled with CFSE and co-transferred to Rag1 knockout mice. The dot-plot and histogram present the percentages of Trim30+/+
(CD45.1 high) and Trim302/2 (CD45.1 low) donor CD4+ T cells on day 0 after adoptive transfer into the Rag1 knockout mice (left panel; day0). The
wild-type (CD45.1+) and Trim302/2 (CD45.12) CD4+ T cell distributions with the decreasing levels of CFSE intensities at day 4 after the adoptive
transfer are shown on the right. The y axes in histogram plot represent the percentage of maximum counts. The percentages of proliferating cells are
shown with those of the non-proliferating cells. (B) Average percentages of proliferating cells (Dividing) and non-dividing cells (Non) from three
independent experiments are shown. (C) The numbers of adoptively transferred wild-type and Trim302/2 CD4+ T cells in recipient spleens after 4
days were measured from four individual mice. The P-value was calculated using a t–test. *, P,0.05; **, P,0.005. Error bars in B and C denote the s.d.
doi:10.1371/journal.pone.0095805.g005
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synthesized from 2 mg of the isolated RNA using SuperScript II
Reverse Transcriptase (Invitrogen) with random hexamers or
oligo-dT as the primers. After synthesis, cDNA was diluted 1:10 in
triple distilled water (TDW), and 3 ml was used for real-time PCR
using a Bio-Rad CFX. Gene expression levels were normalized to
GAPDH RNA levels. The following primers were used: Trim30
forward primer (59-TTCCAGAGGAGGAGCAGAAGGTG-39),
Trim30 reverse primer (59-TCACAAAGCCAGCAGATGAC-
CATC-3), GAPDH forward primer (59- GGCAAATTCAACGG-
CACAGTCAAG-39), GAPDH reverse primer (59-
TCGCTCCTGGAAGATGGTGATGG-39), IL-6 forward primer
(59- TAAGCATATCAGTTTGTGGAC-39), IL-6 reverse primer
Figure 6. Effects of Trim30 deficiency on classical TCR signaling. (A) Primary CD4+ T cells from Trim30+/+and Trim302/2mice were stimulated
with the indicated antibodies for 3 days, and then the supernatants were collected and assayed for IL-2 production by ELISA. Concentration of IL-2 is
shown for three independent experiments. Error bars represent s.d. (B) The numbers of CD252 and CD692 expressing CD4+ T cells from Trim30+/+
(gray area) and Trim302/2 (white area) mice 24 h after treatment with anti-CD3 (2 mg/ml) antibody are shown. Mean fluorescence intensity (MFI)
values are given. (C) Purified CD4+ T cells from Trim30+/+ and Trim302/2 mouse spleens were stimulated with anti-CD3 antibody (2 mg/ml) and anti-
IgG (10 mg/ml) for the times indicated at the top. Lysates from CD4+ T cells were analyzed by immunoblotting using the indicated antibodies. The bar
graph shows the averages of the band intensities. Data are representative results of at least three independent experiments. Error bars in A and C
denote the s.d.
doi:10.1371/journal.pone.0095805.g006
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(59- TCATATTGTCAGTTCTTCGTAG-39), IL-12p40 forward
primer (59- GAAGTGATATTGATAAGAAACCAG-39), IL-
12p40 reverse primer (59- AAGCATATACCACCGATACC-39),
TNFa forward primer (59- ATGTCCATTCCTGAGTTCTG-39),
TNFa reverse primer (59- AATCTGGAAAGGTCTGAAGG-39),
IFNa forward primer (59- AGGACTCATCTGCTGCATG-
GAATG-39), IFNa reverse primer (59- CACACAGGCTTT-
GAGGTCATTGAG-39), IFNb forward primer (59- CCACTT-
GAAGAGCTATTACTG-39), IFNb reverse primer (59-
AATGATGAGAAAGTTCCTGAAG-39).
Adoptive Transfer of T cells
CD4+ T cells from spleens of 6- to 8-week-old CD45.1+
congenic C57BL/6 mice (wild-type) or CD45.2+ Trim302/2 mice
were purified using CD4 (L3T4) MicroBeads (Miltenyi Biotech)
and labeled with 5 mM CFSE. Then, 56106 wild-type and
Trim302/2 CD4+ T cells (mixed at a ratio of 1:1) were injected
intravenously into sex- and age-matched Rag12/2 mice. Mice
were sacrificed 4 days after the transfer. CFSE dilutions patterns of
cells from wild-type and Trim302/2 mouse spleens were measured
by FACS.
Statistical Analysis
GraphPad Prism 5.0 software was used for statistical analysis.
An unpaired two-tailed t-test was used to compare experimental
groups. Data shown in the figures represents the mean 6 SD.
Differences were considered statistically significant when the P-
values were less than 0.05.
Bone Marrow-derived Macrophage (BMDM) Isolation and
Culture
For generating BMDMs, bone marrow cells were collected from
femurs and tibias of Trim30+/+ and Trim302/2 mice by flushing
with Dulbecco’s phosphate buffered saline (DPBS). BMDMs were
differentiated for 6–7 days in DMEM (Invitrogen) supplemented
with 20% FBS (Gibco), 50 U/ml penicillin, 50 mg/ml streptomy-
cin, and 20% cultured supernatant from L929 cells.
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